The cleaning validation processes of companies manufacturing active ingredients continues to be at the forefront of concerns of federal regulators, especially to protect the health and well-being of consumers. Per cGMP and FDA guidelines, cleaning procedures must be repeatable, verifiable and recorded.
In recent times, numerous pharmaceutical companies have been publicly criticized for not properly cleaning their equipment that comes into contact with Active Pharmaceutical Ingredients (APIs) and thus contaminating other products that are manufactured by that machinery. These contaminated products can then be consumed by patients, potentially causing life-threatening complications. More than ever, it’s become essential for these pharmaceutical manufacturing companies to ensure the cleanliness of every piece of apparatus used in manufacturing these products.
Here’s how one multinational pharmaceutical company became GMP compliant whilst increasing production and reducing costs. Find out more by submitting the form below.
Access our previous white papers also available for download.
In the world leading North American pharmaceutical and biotechnology markets, businesses expect high quality and cutting edge solutions with an equally superior level of local support and after-sales service:
For this reason, we are proud to announce a new partnership between Tema Sinergie and STEQ America.
The moment demands new ways of thinking and acting. Always focused on our customers and on the dynamic way they work in their daily lives, STEQ America proudly announces our new exclusive commercial relationship with castus® gmbH & Co. KG …
Hazardous wastes used in testing and research laboratories can cause critical illness, sometimes ending in the loss of life, and can be responsible for detrimental environmental threats when improperly collected or stored.